MD,Professor & Chief Physician; Chief Clinical Medical Expert, Cell and Gene Therapy Research Center, Southern University of Science and Technology (SUSTech),
Key Positions & Affiliations
Chief Clinical Medical Expert, SUSTech Cell and Gene Therapy Research Center (2024–Present).
Founding Director, China’s First Cancer Gene Therapy Center (Beijing Haidian Hospital, 2004) & Comprehensive Treatment Center (Beijing Yanhua Hospital, 2007).
Executive Vice Chairman, International Medical Tourism Branch (China Healthcare International Exchange Promotion Association).
Member, Johns Hopkins Internal and Surgical Society.
Education & Training
MD, Nanjing Medical University (1982).
Postdoctoral Research, Oncology Surgery Laboratory, Johns Hopkins University School of Medicine (1990–1995).
Published in Circulation, Journal of Clinical Investigation*, and *Surgery.
Career Highlights
Pioneered Integrated Cancer Care: Combined gene therapy (P53, CAR-T, NK), minimally invasive techniques, and traditional therapies to create multidisciplinary (MDT)
treatment protocols for advanced cancers.
Global Patient Impact: Treated 1,000+ international patients from 40+ countries (e.g., U.S., Germany, UK, India), establishing China’s most internationally recognized
oncology department.
Translational Innovation: Led the development of China’s first gene therapy centers, bridging cutting-edge research (gene/immune therapies) with clinical practice.
Media & Recognition
Featured by Associated Press Washington Post, CBS and 20+ global media outlets for breakthroughs in cancer gene therapy.
Covered by European and Asian national broadcasters (e.g., German TV, Swedish National TV, Korean TV).
Professional Contributions
Clinical Leadership: Over 40 years in surgical oncology, general surgery, and translational medicine. – Research Focus: Advanced personalized cancer therapies,
cryosurgery, and biotech applications.
Awards & Governance : Advisor to national health foundations; key contributor to cancer policy committees in China.
